CIK 0000879169 · Large accelerated filer
INCYTE CORP
Sign in to watch- Ticker
- INCY
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943136539
- Phone
- 3024986700
- Business address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,959,897
- in 5 filings, $33.0M under 10b5-1 plans
Net −$32,959,897. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-16 | Hoffman Richard A. EVP & General Counsel | Grant or award · Performance Shares | +18,487 | 18,487 | ||
| 2026-07-16 | Hoffman Richard A. EVP & General Counsel | Grant or award · Employee Stock Option (right to buy) | +31,923 | 31,923 | ||
| 2026-07-16 | Gardner David H EVP, Chief Strategy Officer | Grant or award | +7,395 | 16,824 | ||
| 2026-07-16 | Gardner David H EVP, Chief Strategy Officer | Grant or award · Performance Shares | +18,487 | 18,487 | ||
| 2026-07-16 | Gardner David H EVP, Chief Strategy Officer | Grant or award · Employee Stock Option (right to buy) | +31,923 | 31,923 | ||
| 2026-07-16 | Basi Ramitpal K EVP, Human Resources | Grant or award | +4,991 | 11,497 | ||
| 2026-07-16 | Basi Ramitpal K EVP, Human Resources | Grant or award · Performance Shares | +12,479 | 12,479 | ||
| 2026-07-16 | Basi Ramitpal K EVP, Human Resources | Grant or award · Employee Stock Option (right to buy) | +21,548 | 21,548 | ||
| 2026-07-16 | Mayes Patrick A EVP & Chief Scientific Officer | Grant or award | +5,916 | 63,628 | ||
| 2026-07-16 | Mayes Patrick A EVP & Chief Scientific Officer | Grant or award · Performance Shares | +14,790 | 14,790 | ||
| 2026-07-16 | Mayes Patrick A EVP & Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +25,538 | 25,538 | ||
| 2026-07-16 | Issa Mohamed Khairie EVP, Head of U.S. Commercial | Sale 10b5-1 | −1,093 | $115.01 | $126K | 63,940 |
| 2026-07-16 | Issa Mohamed Khairie EVP, Head of U.S. Commercial | Grant or award 10b5-1 | +7,857 | 71,797 | ||
| 2026-07-16 | Issa Mohamed Khairie EVP, Head of U.S. Commercial | Grant or award · Performance Shares 10b5-1 | +19,643 | 19,643 | ||
| 2026-07-16 | Issa Mohamed Khairie EVP, Head of U.S. Commercial | Grant or award · Employee Stock Option (right to buy) 10b5-1 | +33,918 | 33,918 | ||
| 2026-07-16 | Tray Thomas Principal Accounting Officer | Grant or award | +2,834 | 21,699 | ||
| 2026-07-16 | Tray Thomas Principal Accounting Officer | Grant or award · Employee Stock Option (right to buy) | +4,079 | 4,079 | ||
| 2026-07-16 | Stein Steven H CMO & Head of Late-Stage Dev. | Sale 10b5-1 | −1,877 | $114.73 | $215K | 21,118 |
| 2026-07-16 | Stein Steven H CMO & Head of Late-Stage Dev. | Grant or award 10b5-1 | +9,798 | 30,916 | ||
| 2026-07-16 | Stein Steven H CMO & Head of Late-Stage Dev. | Grant or award · Performance Shares 10b5-1 | +24,496 | 24,496 |
Page 7 of 15 · 293 trades